![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Prescription & OTC Drug Info | Side Effects, Interactions & Dosages
MPR provides drug monographs, drug news and e-prescribing service for healthcare professionals. We provides drug dosing, interactions, recalls and more for medical professionals.
Prescription Device Cleared for Patients With Drug-Resistant …
Apr 20, 2023 · The Food and Drug Administration (FDA) has cleared the NTX100 Tonic Motor Activation (TOMAC) System for the treatment of medication-refractory moderate to severe …
Clotrimazole Prescription & Dosage Information - MPR
Clotrimazole prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and Clotrimazoleside effects.
Hydrocodone/acetaminophen (325mg) - MPR
Hydrocodone bitartrate, acetaminophen; 5mg/325mg, 7.5mg/325mg, 10mg/325mg; scored tabs. Use lowest effective dose for shortest duration. Individualize. 5mg/325mg: 1–2 tabs every …
Lidocaine Ointment Prescription & Dosage Information - MPR
Lidocaine Ointment prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and Lidocaine Ointmentside effects.
Permethrin Prescription & Dosage Information - MPR
Permethrin prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and Permethrinside effects.
The MPR Drug Reference Database for Healthcare Practitioners
View our rich drug database that contains concise drug information on more than 4,000 drugs and provides indication, dose, contraindications, precautions, interactions, adverse reactions ...
DEBROX Prescription & Dosage Information - MPR
DEBROX prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and DEBROXside effects.
High-Alert Medications - MPR
Oct 21, 2014 · High-Alert Medications according to ISMP guidelines
FDA Approves First Generics of Heart Failure Combo Drug Entresto
Jun 3, 2024 · The Food and Drug Administration (FDA) has approved the first generics of Entresto ® (sacubitril and valsartan; Novartis) tablets.. The combination of sacubitril, a …